Sculptra nodules form when PLLA (poly-L-lactic acid) particles, which stimulate collagen, do not spread evenly through the tissue but clump together in one spot. Sculptra is injected as a suspension of PLLA particles diluted in water. Over the course of one to three days after injection, the water component is absorbed, leaving only the PLLA particles. If these particles clump together before they naturally blend with the tissue, excessive collagen may be produced in that area, resulting in small palpable nodules.
Nodules can be broadly divided into two types. One type is palpable early on due to particle clumping, and the other type forms over time during the collagen response process. In either case, the common underlying factor is "localized over-concentration of particles."
Because of this mechanism, uniform dispersion is key for collagen-stimulating injections such as Sculptra and JUVELOOK Volume, and the entire process — dilution, injection, and post-procedure care — is directly linked to nodule prevention.





